Tag: TPV

Medtronic Congenital Heart Disease Studies Show Strong 10-Year Performance for Melody Transcatheter Pulmonary Valve and Primary Results from the Harmony Pivotal Trial

Coronary/Structural Heart by 0 comments

Milestone Results Presented as Late-Breaking Clinical Science at SCAI 2020 DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. Ten-year outcomes from the Melody™ Transcatheter Pulmonary Valve (TPV) Therapy […]

Continue Reading →

Two-Year Feasibility Study Results Encouraging with Medtronic Harmony(TM) Transcatheter Pulmonary Valve

Coronary/Structural Heart by 0 comments

DUBLIN and SAN DIEGO – April 26, 2018 – Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study. Presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific Sessions, data from 18 patients followed out to two […]

Continue Reading →

Medtronic (MDT) Snags FDA Approval for First of Its Kind Melody Transcatheter Pulmonary Valve

Coronary/Structural Heart by Comments are Disabled

Press Release  View printer-friendly version Medtronic Melody Transcatheter Pulmonary Valve First of Its Kind to Receive FDA Approval for Implantation in Failed Surgical Pulmonary Heart Valves Newly Approved Indication in U.S. Expands Treatment Options to More Patients with Congenital Heart Disease DUBLIN – March 14, 2017 – Medtronic plc (NYSE: […]

Continue Reading →